CDC Website CDC Website

To Join the NPIN community or

Home » Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)

Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)

This initiative will support projects that exploit Omics assays to address outstanding questions regarding molecular regulation of persistent HIV (e.g. latency or reservoirs) in the context of chronic substance use or substance use disorder (SUD).
Funding Category
Eligible Organizations
Number of Awards Given
2-3 awards.
Notes
Application budgets are limited to direct costs of $450k/year for each year of the R61 phase and $650k/year for each year of the R33 phase, and should reflect the actual needs of the proposed project.
Letter of Intent Date
6/17/18
Application Due Date
7/17/18
Project Start Date
4/1/19
Application Contact
Aida
Vasquez
Grants Management Specialist
United States
301- 480-2154
vasquez@mail.nih.gov
Technical Contact
John
Satterlee, Ph.D.
Health Scientist Administrator
satterleej@nida.nih.gov
United States
301- 435-1020
Fund Duration
Application budgets are limited in time to a maximum of three years for the R61 phase and two years for the R33 phase.
Subjects

Fund Number: 

5360

Fund ID: 

RFA-DA-19-003